Andy Birchfield in the News

Photo of Andy Birchfield Andy D. Birchfield, Jr.
Lead Attorney in $4.85 Billion Vioxx Settlement
 

Articles 91 to 97 of 97 for attorney Andy Birchfield.

Lawyers Organizing for Mass Suits Over Vioxx

THE NEW YORK TIMES | November 5, 2004

Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the

Lawyers Organizing for Mass Lawsuits over Vioxx

November 5, 2004

Hundreds of plaintiffs' lawyers who claim that people were injured or killed by the painkiller Vioxx plan to meet next week to lay the groundwork for a nationwide legal assault against the drug's maker, Merck.

How bad will the lawsuits get, Really, Really Bad.

November 1, 2004

Surveying the wreckage of the worst pharmaceutical tort litigations of the past, investors naturally want to know: Will Vioxx be the next Baycol, or Rezulin, or fen-phen? Our prediction is: yes, but bigger.

Response to Merck's Press Conference regarding Vioxx

October 13, 2004

Merck's press conference was very disappointing, according to Andy Birchfield, "Instead of accepting responsibility for putting a dangerous drug on the market and keeping it there for so long, Merck spent an hour defending itself."

Lawsuits looming as Vioxx Recalled

October 13, 2004

Lawsuits. Lawsuits. Lawsuits. And they're coming fast. The recall came after testing revealed the risk of heart attack or stroke doubled for those taking Vioxx.

News on Vioxx: A Shot in the Arm for Plaintiffs Bar

October 1, 2004

The plaintiffs bar was heartened when pharmaceutical giant Merck & Co. stopped sales of Vioxx, a popular arthritis drug that relieves aches and pains, but increases the risk of heart attacks and strokes.

Merck recalls Vioxx

September 30, 2004

A new FDA study found patients taking a high dose of Vioxx were three times more likely to have a heart attack. As a result, Merck & Co. is pulling the arthritis drug from the market.